Company · Healthtech & Bio

Biohope

biohope.eu ↗ ·Madrid ·Seed

Biohope is a Madrid-based, commercial-stage biomedical company developing precision-medicine in vitro diagnostic (IVD) tools for chronic inflammatory and autoimmune conditions. Its flagship product, Immunobiogram®, is a CE-marked, ISO 13485-certified functional cellular assay that personalizes immunosuppressive therapy for kidney transplant patients by measuring individual immune cell response to different drugs. Founded in 2015, the company has received EU Horizon 2020 non-dilutive grants and regional Madrid innovation funding alongside private investment.

Founded
2015
Founders
1
News
0
Rounds
0
Investors
3
SectorsPrecision Medicine, In Vitro Diagnostics, Immunology, Transplant Diagnostics, Autoimmune Diseases Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing

Profile updated 31 Jul 2026

Founders

Isabel Portero
Founder & CSO

Global models 5

Grail
United States · grail.com ↗
Blood-based precision diagnostic testing for early disease detection, the same core model of a proprietary blood assay driving personalized clinical decisions.
$2.0BComparable
Tempus AI
United States · www.tempus.com ↗
Precision-medicine diagnostics platform that uses molecular/clinical data to personalize patient treatment, mirroring Biohope's personalize-therapy-via-diagnostics model.
$1.3BComparable
Guardant Health
United States · guardanthealth.com ↗
Liquid-biopsy diagnostic tests that guide personalized treatment decisions, the same precision-diagnostics-to-therapy-selection model.
$550MComparable
Freenome
United States · www.freenome.com ↗
Blood-based multiomics diagnostic platform for personalized disease detection, similar blood-test-driven precision medicine approach.
$524MComparable
CareDx
United States · caredx.com ↗
The closest direct comparable: blood-based diagnostic tests (AlloSure/AlloMap) that personalize immunosuppressive therapy for transplant patients.
$138MComparable

Investors 3

Funding rounds

No announced rounds on record.

News & media

No coverage on record yet.
Start typing to search across everything.
↑↓ navigate↵ openesc close